Article preview reprinted from IN VIVO - September 2008
In Vivo briefly describes these recently founded companies: Clear Catheter Systems, Curant, DendriMed, Mirina, OcuSciences, and Zenobia Therapeutics.
Article preview reprinted from IN VIVO - September 2008
Out of the Blocks Summarizing the technologies of recently founded companies:
Clear Catheter Systems Inc. is developing devices to eliminate clotting in post-surgical drainage tubes. Its lead product, the PleuraFlow catheter, is designed to treat active clogging during bleeding in standard and small diameter chest drainage tubes. Clear Catheter is a collaborative effort between device incubator Medical Device Innovations and the Cleveland Clinic Foundation. The company's technology was developed by CEO Edward Boyle, MD and Marc Gillinov, MD, a heart surgeon with the Cleveland Clinic Heart and Vascular Institute.
Clear Catheter Systems Inc.
2200 NE Neff, Suite 204
Bend, OR 97701
Phone: (541) 382-8346
E-Mail: emb@clearcatheter.com
Web Site: www.clearcatheter.com
Purchase this 495-word article online as a PDF for just $35 and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed. Subscribe to IN VIVO.
Companies mentioned in this article:
Clear Catheter Systems Inc.
Curant Inc.
DendriMed Pty. Ltd.
Mirina Corp.
OcuSciences Inc.
Zenobia Therapeutics Inc.
IN VIVO is the premier strategic business resource for the biopharma, medtech, and diagnostics industries.
IN VIVO delivers:
- Revealing, in-depth coverage of your competitors' strategies
- Incisive projections of future industry trends and their implications for your business
- Expert analysis of key industry developments
- Exclusive interviews with top industry executives and analysts
- In-depth examination of dealmaking, marketing, R&D, regulatory, and finance strategies -- those that were successful and those that missed the mark
- Subscribe to IN VIVO today!
